it must have seemed inconceivable that a rebooted version of the free-market economic liberalism of the previous century would soon return to prominence. But by the start of the next decade, it was very much back on the domestic and international policy agenda. And once again it would have devastating and often deadly consequences on health—both in high-income countries like the U.S. and the UK and in the world’s poorest nations.
